/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

Elevate Ventures
IndianapolisPre-Seed–Series A$20K – $2M
22 people
Lux Capital
New YorkPre-Seed–Series B$100K – $100M
46 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
116 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
22 people
Frazier Healthcare Partners
SeattleGrowth–Late Stage$50M – $400M
103 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Atlas Venture
CambridgeSeed–Series B$500K – $1M
84 people
Kyto Technology and Life Science Inc.
Palo AltoPre-Seed–Seed
136 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
99 people
Maryland TEDCO
ColumbiaPre-Seed–Series A$500K – $1.5M
75 people
Arsenal
New YorkGrowth
111 people
Connecticut Innovations
New HavenPre-Seed–Growth$500K – $2M
29 people
Pear VC
San FranciscoPre-Seed–Series A$150K – $4M
29 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
Patient Square Capital
Menlo ParkGrowth–Late Stage
125 people
Mana Ventures
EsteroPre-Seed–Series A
3 people
NFX
San FranciscoPre-Seed–Series A$250K – $5M
23 people
Correlation Ventures
San FranciscoPre-Seed–Series A$100K – $4M
19 people
NC IDEA
DurhamPre-Seed–Seed
16 people
Initialized Capital
San FranciscoPre-Seed–Seed$1M – $5M
17 people
The E14 Fund
CambridgePre-Seed–Series A$1M – $5M
45 people
ARCH Venture Partners
ChicagoSeed–Series C$50K – $250M
46 people
Sofinnova Ventures
Menlo ParkSeed–Late Stage$100K – $15M
48 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.